Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Exchange Rate Effect (2016 - 2025)

Sunshine Biopharma's Exchange Rate Effect history spans 11 years, with the latest figure at $758585.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 219.41% year-over-year to $758585.0; the TTM value through Dec 2025 reached $855750.0, up 182.02%, while the annual FY2025 figure was $855750.0, 182.02% up from the prior year.
  • Exchange Rate Effect reached $758585.0 in Q4 2025 per SBFM's latest filing, up from -$228322.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $772282.0 in Q3 2024 to a low of -$1.3 million in Q2 2024.
  • Average Exchange Rate Effect over 5 years is -$15086.9, with a median of -$1535.0 recorded in 2021.
  • The largest YoY upside for Exchange Rate Effect was 2048.63% in 2024 against a maximum downside of 14684477.78% in 2024.
  • A 5-year view of Exchange Rate Effect shows it stood at -$20268.0 in 2021, then crashed by 185.37% to -$57839.0 in 2022, then plummeted by 70.52% to -$98626.0 in 2023, then plummeted by 544.15% to -$635298.0 in 2024, then soared by 219.41% to $758585.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Exchange Rate Effect are $758585.0 (Q4 2025), -$228322.0 (Q3 2025), and $335684.0 (Q2 2025).